174 related articles for article (PubMed ID: 22512970)
1. UroLift system for relief of prostate obstruction under local anesthesia.
Barkin J; Giddens J; Incze P; Casey R; Richardson S; Gange S
Can J Urol; 2012 Apr; 19(2):6217-22. PubMed ID: 22512970
[TBL] [Abstract][Full Text] [Related]
2. State of the art: Advanced techniques for prostatic urethral lift for the relief of prostate obstruction under local anesthesia.
Walsh LP
Can J Urol; 2017 Jun; 24(3):8859-8864. PubMed ID: 28646943
[TBL] [Abstract][Full Text] [Related]
3. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
[TBL] [Abstract][Full Text] [Related]
4. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
Woo HH; Chin PT; McNicholas TA; Gill HS; Plante MK; Bruskewitz RC; Roehrborn CG
BJU Int; 2011 Jul; 108(1):82-8. PubMed ID: 21554526
[TBL] [Abstract][Full Text] [Related]
5. Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Cantwell AL; Bogache WK; Richardson SF; Tutrone RF; Barkin J; Fagelson JE; Chin PT; Woo HH
BJU Int; 2014 Apr; 113(4):615-22. PubMed ID: 24765680
[TBL] [Abstract][Full Text] [Related]
6. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Chin PT; Bolton DM; Jack G; Rashid P; Thavaseelan J; Yu RJ; Roehrborn CG; Woo HH
Urology; 2012 Jan; 79(1):5-11. PubMed ID: 22202539
[TBL] [Abstract][Full Text] [Related]
7. Three year results of the prostatic urethral L.I.F.T. study.
Roehrborn CG; Rukstalis DB; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rashid P
Can J Urol; 2015 Jun; 22(3):7772-82. PubMed ID: 26068624
[TBL] [Abstract][Full Text] [Related]
8. Prospective multi-center study elucidating patient experience after prostatic urethral lift.
Shore N; Freedman S; Gange S; Moseley W; Heron S; Tutrone R; Brown T; Barkin J
Can J Urol; 2014 Feb; 21(1):7094-101. PubMed ID: 24529008
[TBL] [Abstract][Full Text] [Related]
9. Alternative treatment of prostatic urethral obstruction secondary to benign prostatic hypertrophy. Non-surgical balloon catheter prostatic dilatation.
Castaneda F; Letourneau JG; Reddy P; Hulbert J; Hunter DW; Castaneda-Zuniga WR; Amplatz K
Rofo; 1987 Oct; 147(4):426-9. PubMed ID: 2446357
[TBL] [Abstract][Full Text] [Related]
10. Prostatic Urethral Lift: Does Size Matter?
Shah BB; Tayon K; Madiraju S; Carrion RE; Perito P
J Endourol; 2018 Jul; 32(7):635-638. PubMed ID: 29631445
[TBL] [Abstract][Full Text] [Related]
11. Office-based therapies for benign prostatic hyperplasia: a review and update.
Das AK; Leong JY; Roehrborn CG
Can J Urol; 2019 Aug; 26(4 Suppl 1):2-7. PubMed ID: 31481142
[TBL] [Abstract][Full Text] [Related]
12. [Urolift®, a new minimally invasive treatment for patients with low urinary tract symptoms secondary to BPH. Preliminary results].
Garrido Abad P; Coloma Del Peso A; Sinues Ojas B; Fernández Arjona M
Arch Esp Urol; 2013; 66(6):584-91. PubMed ID: 23985459
[TBL] [Abstract][Full Text] [Related]
13. The UroLume endoprosthesis: a summary of the European and North American experience.
Oesterling JE
Prog Clin Biol Res; 1994; 386():561-75. PubMed ID: 7528427
[TBL] [Abstract][Full Text] [Related]
14. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience.
Kahn SA; Alphonse P; Tewari A; Narayan P
J Urol; 1998 Nov; 160(5):1695-700. PubMed ID: 9783934
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia. Our initial experience with Urolift® under local anaesthesia and sedation.
Cayuelas Rubio C; Pallás Costa Y; Juan Escudero J; Ramos de Campo M; García Ibáñez J; Mitjana Biosca S; Monzó Cataluña A; Rechi Sierra K; Fernández Arjona M; López Alcina E
Actas Urol Esp (Engl Ed); 2019 Nov; 43(9):488-494. PubMed ID: 31160158
[TBL] [Abstract][Full Text] [Related]
16. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.
Hoekstra RJ; Van Melick HH; Kok ET; Ruud Bosch JL
BJU Int; 2010 Sep; 106(6):822-6. PubMed ID: 20184573
[TBL] [Abstract][Full Text] [Related]
17. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.
Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A
Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311
[TBL] [Abstract][Full Text] [Related]
18. [Intra-prostatic UroLift(®) implants for benign prostatic hyperplasia: preliminary results of the four first cases performed in France].
Delongchamps NB; Conquy S; Defontaines J; Zerbib M; Peyromaure M
Prog Urol; 2012 Sep; 22(10):590-7. PubMed ID: 22920338
[TBL] [Abstract][Full Text] [Related]
19. Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study.
Rukstalis D; Grier D; Stroup SP; Tutrone R; deSouza E; Freedman S; David R; Kamientsky J; Eure G
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):411-419. PubMed ID: 30542055
[TBL] [Abstract][Full Text] [Related]
20. Transurethral resection of the prostate (TURP)--in the treatment of benign prostatic hypertrophy (BPH) in Mekelle, Ethiopia.
Alemu MH
Ethiop Med J; 2009 Jan; 47(1):65-9. PubMed ID: 19743783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
